Wilhelm S M, Shao Z H, Housley T J, Seperack P K, Baumann A P, Gunja-Smith Z, Woessner J F
Institute for Bone and Joint Disorders, Miles Research Center, Miles, Inc., West Haven, Connecticut 06516.
J Biol Chem. 1993 Oct 15;268(29):21906-13.
Human pro-MMP-3 (pro-matrix metalloproteinase-3) was purified from three sources: articular cartilage and conditioned media from synovial fibroblasts and Chinese hamster ovary cells expressing recombinant pro-MMP-3. All three preparations reacted with two monoclonal antibodies specific for human fibroblast pro-MMP-3. Each preparation of active MMP-3 possessed properties identical to those previously reported for the cartilage acid metalloproteinase (MMP-6; Azzo and Woessner, J. F., Jr. (1986) J. Biol. Chem. 261, 5434-5441): an acid pH optimum of 5.3-5.5 for digestion of cartilage aggrecan; digestion of oxidized insulin B-chain at Ala14-Leu15 and Tyr16-Leu17 in a ratio of 3:1; and heat stability at neutral pH. Further characterization of MMP-3 establishes that the acid pH optimum for cartilage aggrecan is not due to substrate denaturation since the same optimum is found by viscosity assay, by SDS-polyacrylamide gel electrophoresis assay of G1 domain, and by digestion of aggrecan in fresh cartilage fragments in vitro. Fibronectin was also digested optimally at pH 5.5 and NH2-terminal sequence analysis revealed no pH change in a major proteolytic site of cleavage at the Pro689-Leu690 bond. The specificity constant kcat/Km is maximal at pH 5.5 as determined in a quenched fluorescence peptide assay. This is due to an increase in kcat at pH 5.5 without any substantial effect on Km. The affinity of MMP-3 for calcium is decreased about 10-fold at pH 5.3 compared to neutral pH. Finally, the neutral cartilage metalloproteinase is identified as 72-kDa pro-MMP-2 based on M(r), specificity of insulin B-chain cleavage, and reactivity with a specific polyclonal antibody to human MMP-2.
人源前基质金属蛋白酶-3(pro-MMP-3)从三种来源进行纯化:关节软骨、滑膜成纤维细胞的条件培养基以及表达重组前基质金属蛋白酶-3的中国仓鼠卵巢细胞。这三种制剂均与两种针对人成纤维细胞前基质金属蛋白酶-3的单克隆抗体发生反应。每种活性基质金属蛋白酶-3制剂所具有的特性与先前报道的软骨酸性金属蛋白酶(MMP-6;Azzo和Woessner,J.F.,Jr.(1986年)《生物化学杂志》261卷,5434 - 5441页)相同:消化软骨聚集蛋白聚糖的最适酸性pH为5.3 - 5.5;以3:1的比例在Ala14 - Leu15和Tyr16 - Leu17处消化氧化胰岛素B链;以及在中性pH下具有热稳定性。对基质金属蛋白酶-3的进一步表征表明,软骨聚集蛋白聚糖的最适酸性pH并非由于底物变性,这是因为通过粘度测定、G1结构域的SDS - 聚丙烯酰胺凝胶电泳测定以及体外新鲜软骨碎片中聚集蛋白聚糖的消化均发现了相同的最适pH。纤连蛋白在pH 5.5时也能被最佳消化,并且NH2末端序列分析显示在Pro689 - Leu690键的主要蛋白水解切割位点没有pH变化。在淬灭荧光肽测定中确定,特异性常数kcat/Km在pH 5.5时最大。这是由于在pH 5.5时kcat增加而对Km没有任何实质性影响。与中性pH相比,基质金属蛋白酶-3对钙的亲和力在pH 5.3时降低约10倍。最后,基于分子量、胰岛素B链切割的特异性以及与针对人基质金属蛋白酶-2的特异性多克隆抗体的反应性,中性软骨金属蛋白酶被鉴定为72 kDa的前基质金属蛋白酶-2。